Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
VOLTAREN 100MG SUPP
- Sku : I-006742
Key features
VOLTAREN 100MG SUPP is a suppository formulation containing diclofenac sodium 100 mg. It acts by inhibiting cyclooxygenase enzymes (COX‑1 and COX‑2), reducing prostaglandin synthesis to alleviate inflammation, pain and fever. It is indicated for symptomatic treatment of pain and inflammation in rheumatic diseases such as rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, and for acute painful or inflammatory conditions where rectal diclofenac is appropriate, including acute gout and post‑operative or post‑traumatic pain. Supplied as a pack of 5 suppositories for prescription use.- Brand: VOLTAREN
- Active Ingredient: DICLOFENAC SODIUM
- Strength: 100mg
- Dosage Form: Suppository
- Pack Size: 5 Suppositories
- Route: Rectal use
- Prescription Status: Prescription
- Therapeutic Class: Analgesic
- Pharmacological Group: Acetic Acid Derivatives (NSAIDs)
- Drug Class: Nonsteroidal anti-inflammatory drug (NSAID); acetic acid derivative; non-selective COX inhibitor.
- Manufacturer: DELPHARM HUNINGUE S.A.S.
- Country of Origin: France
- SFDA Registration No.: 130-9-16
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Pain Type: General, Muscular, Joint
- Nsaid: Yes
- Opioid: No
Frequently bought together
Indications
Approved Uses
Symptomatic treatment of pain and inflammation in rheumatic diseases (e.g., rheumatoid arthritis, osteoarthritis, ankylosing spondylitis) and acute painful/inflammatory conditions where rectal diclofenac is appropriate (e.g., acute gout, post‑operative/post‑traumatic pain).
Dosage & Administration
Dosing by Condition
For osteoarthritis: 100-150 mg/day in divided doses (50 mg twice or three times daily, or 75 mg twice daily); for rheumatoid arthritis: 150-200 mg/day in divided doses; for ankylosing spondylitis: 100-125 mg/day (25 mg four times daily with optional extra 25 mg at bedtime). Maximum recommended daily dose is 200 mg/day. Rectal suppository dosing specifically is not detailed in provided sources; the 100 mg suppository was used as a single dose in clinical studies but routine maintenance dosing is not specified
Initial Dose
100 mg once daily as a single rectal suppository.
Maximum Dose
Rectal: Insert 1 suppository (100 mg) once daily; do not exceed 150 mg/day total diclofenac from all formulations.
Children's Dosage
100mg suppositories are not suitable for children and adolescents. For juvenile rheumatoid arthritis (ages 1-12), the dose is 1-3 mg/kg daily in divided doses, not to exceed 150mg/day.
Dose Adjustment Notes
Use the lowest effective dose for the shortest duration. In older adults or higher-risk patients, start at the lowest dose and monitor closely. Avoid/use with extreme caution in severe renal impairment, severe hepatic impairment, or active GI bleeding/ulcer. Do not exceed a total diclofenac dose of 150 mg/day from all formulations combined (typical adult maximum).
Side Effects
Common Side Effects
GI: dyspepsia/abdominal pain, nausea, diarrhea; CNS: headache, dizziness; local: rectal irritation/burning/itching; labs: possible elevation of liver enzymes with systemic exposure.
Side Effect Frequency
Common: GI symptoms (nausea, dyspepsia/abdominal pain, diarrhea), headache/dizziness, rash, and local rectal irritation; elevated transaminases can occur. Serious GI ulcer/bleeding, severe skin reactions (e.g., SJS/TEN), hepatotoxicity, renal injury, and CV thrombotic events are uncommon/rare but clinically important.
Safety & Warnings
Contraindications
Contraindications: hypersensitivity to diclofenac/other NSAIDs; history of asthma/urticaria/allergic-type reactions after aspirin/NSAIDs (AERD); active GI bleeding or peptic ulcer; peri-operative pain in CABG surgery; proctitis/rectal inflammation or recent rectal bleeding (suppository route). Avoid/contraindicated in 3rd trimester pregnancy.
Warnings & Precautions
Key warnings/precautions: use lowest effective dose for shortest duration; CV risk (avoid in established CVD when possible; monitor BP/edema); GI risk (consider gastroprotection in high-risk patients; watch for bleeding); renal risk (monitor renal function, avoid dehydration and high-risk combinations); hepatic monitoring (stop if LFTs rise or symptoms); hypersensitivity/AERD; severe skin reactions; may mask infection/fever; avoid concomitant NSAIDs.
Drug Interactions
Drug Interactions
Clinically important interactions: anticoagulants (e.g., warfarin) and antiplatelets/SSRIs/SNRIs (↑ bleeding); other NSAIDs/salicylates and corticosteroids (↑ GI toxicity); ACEi/ARB/diuretics (↓ antihypertensive/diuretic effect, ↑ AKI risk-“triple whammy”); lithium (↑ levels); methotrexate (↑ toxicity); cyclosporine/tacrolimus (↑ nephrotoxicity); digoxin (↑ levels).
Interaction Severity
MAJOR: anticoagulants/antiplatelets (e.g., warfarin) and SSRIs/SNRIs (↑ bleeding risk), other NSAIDs (↑ GI/renal risk), methotrexate (↑ toxicity), lithium (↑ levels/toxicity). MODERATE: ACE inhibitors/ARBs and diuretics (↓ antihypertensive/diuretic effect, ↑ AKI risk), cyclosporine/tacrolimus (↑ nephrotoxicity), digoxin (↑ levels).
Food Interaction
Not applicable for rectal administration; food does not meaningfully affect absorption from a suppository.
Special Populations
Breastfeeding
Caution
Children
100mg suppositories are not suitable for children and adolescents. For juvenile rheumatoid arthritis (ages 1-12), the dose is 1-3 mg/kg daily in divided doses, not to exceed 150mg/day.
Elderly
Start at the lower end of the dosing range. Use the lowest effective dose for the shortest duration possible due to increased risk of side effects, particularly GI bleeding.
Kidney Impairment
No adjustment for mild-moderate renal impairment but use with caution and monitor renal function; avoid/contraindicated in advanced/severe renal impairment (commonly CrCl <30 mL/min) or if renal function deteriorates.
Storage & Patient Advice
Missed Dose
Insert/use as soon as remembered unless it is close to the next scheduled dose; if close, skip the missed dose and resume the regular schedule. Do not double doses.
Stopping the Medicine
Can be stopped without tapering; if used chronically, stop and seek medical review if symptoms recur or if adverse effects occur.
Overdose
Overdose may cause nausea/vomiting, epigastric pain, GI bleeding, dizziness/drowsiness, tinnitus; severe cases: hypotension/hypertension, acute kidney injury, metabolic acidosis, respiratory depression, seizures, coma, anaphylactoid reactions. Management is supportive (airway/breathing/circulation, fluids, treat seizures), consider activated charcoal if recent ingestion; no specific antidote-seek urgent medical care/poison center.
Patient Counseling
Rectal use: insert suppository as directed (preferably after bowel movement); use the lowest effective dose for the shortest duration; avoid using with other NSAIDs (including OTC ibuprofen/naproxen; low-dose aspirin only if prescribed); seek urgent care for GI bleeding (black/tarry stools, vomiting blood), chest pain/shortness of breath, stroke symptoms, severe rash, or jaundice; avoid alcohol to reduce GI risk; caution with driving if dizzy; tell your clinician about anticoagulants/antiplatelets, SSRIs/SNRIs, steroids, ACEI/ARB/diuretics, and kidney/liver/heart disease; avoid if proctitis/rectal bleeding unless advised; store below 30°C.
Monitoring Requirements
If prolonged/repeated use: monitor blood pressure, renal function (SCr/BUN ± electrolytes), liver enzymes (AST/ALT), and CBC; monitor for GI bleeding and cardiovascular risk, especially in high-risk patients.
Pharmacology
Mechanism of Action
Inhibits COX-1 and COX-2, reducing prostaglandin synthesis and thereby decreasing inflammation, pain, and fever.
Duration of Effect
Approximately 8-12 hours (clinical analgesic/anti-inflammatory effect), supporting once-daily 100 mg suppository use in many patients.
Metabolism
Extensive hepatic metabolism primarily via CYP2C9 (with minor CYP3A4 contribution) to hydroxylated metabolites (e.g., 4′-hydroxy-diclofenac) followed by glucuronidation/sulfation; metabolites have minimal activity.
Product Information
Available Dosage Forms
For diclofenac (Voltaren brand varies by country): suppository; oral tablets (immediate/enteric‑coated and modified/extended‑release); injectable solution; topical gel; ophthalmic drops (diclofenac ophthalmic products exist).
Composition per Dose
Each suppository: 100 mg diclofenac sodium
Generic Availability
Yes
OTC Alternatives
Paracetamol (acetaminophen) and ibuprofen (if no NSAID contraindications); topical NSAIDs (e.g., diclofenac gel) may be an OTC option depending on local availability.
Pain Type
General, Muscular, Joint
Nsaid
Yes
Opioid
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)













